Concepedia

M. Afanasieva

MA

Statistics

Publications

7

Citations

97

H-Index

7

Active since

2010

Affiliations

Institute of Experimental Cardiology(Current)

Ministry of Health of the Russian Federation

National Medical Research Center of Cardiology

M. Afanasieva is an author at Institute of Experimental Cardiology specializing in cardiovascular disease, atherosclerosis, and epidemiology.

ORCID

Top concepts

Publications per year

2010–2021

7

Publications

7

Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia

O. Afanasieva, O. A. Razova, M. Afanasieva et al. · Atherosclerosis · 2018 · 18 citations

, , +8

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

N. A. Tmoyan, O. Afanasieva, M. Afanasieva et al. · Biomolecules · 2021 · 18 citations · Full text

Ig apheresis for the treatment of severe DCM patients

S. Pokrovsky, Maya Safarova, Marina A. Saidova et al. · Atherosclerosis Supplements · 2013 · 14 citations

, , +7

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis

O. Afanasieva, Ekaterina Pylaeva, E. Klesareva et al. · Terapevticheskii arkhiv · 2016 · 14 citations · Full text

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level

O. Afanasieva, E. Klesareva, O. A. Razova et al. · Journal of Cardiovascular Development and Disease · 2020 · 12 citations · Full text

1–5 of 7